Research progress on risk factors and treatment of thromboembolism caused by Mycoplasma pneumoniae infection in children
10.3760/cma.j.issn.1673-4912.2025.11.011
- VernacularTitle:儿童肺炎支原体感染引起血栓栓塞的相关危险因素及治疗的研究进展
- Author:
Xiaofei TIAN
1
;
Xiaodong WANG
;
Kaining SHEN
Author Information
1. 河北医科大学研究生学院，石家庄 050031
- Publication Type:Journal Article
- Keywords:
Children;
Mycoplasma pneumoniae;
Coagulation disorders;
Embolism;
Risk factors;
Treatment
- From:
Chinese Pediatric Emergency Medicine
2025;32(11):858-862
- CountryChina
- Language:Chinese
-
Abstract:
The risk factors for thromboembolism caused by Mycoplasma pneumoniae infection include severe Mycoplasma pneumoniae pneumonia，elevated D-dimer levels，abnormal inflammatory markers，platelet abnormalities，lung consolidation，lung necrosis and pleural effusion，and so on.In terms of treatment，tetracycline and quinolone antibiotics have shown new advantages in addressing the recent prevalence of macrolide resistant mycoplasma.Regarding anticoagulant therapy，direct oral anticoagulants represented by rivaroxaban have significant advantages and are safe in children's medication.In addition，the application of traditional Chinese medicine for promoting blood circulation and removing blood stasis needs to be developed.The identification and intervention of risk factors related to coagulation disorders and thromboembolism caused by Mycoplasma pneumoniae infection can help improve treatment effectiveness.
